Prof. Hindrik Mulder

Hindrik Mulder graduated from Medical school at Lund University, Sweden, in 1988 and received his Ph.D in Physiology in 1997. He was a postdoctoral fellow at the Diabetes Center at Southwestern Medical School in Dallas, Texas, from 1998 to 2000. In 2000, he returned to Lund University and was awarded a position as associate professor from the Swedish Research Council. Hindrik Mulder became full professor at the Medical Faculty in 2007. He sees diabetes patients at the Endocrinology Outpatient Unit at Skåne University Hospital.

Hindrik Mulder’s initial research addressed the role of islet amyloid polypeptide in glucose homeostasis and islet function. After his postdoctoral training, islet function with a focus both on lipid and carbohydrate metabolism became his main interest. He established a metabolomics platform, which was used to profile islet and beta-cell metabolism. He also examined the link between neurodegenerative disorders and diabetes. More recently, fuelled by the strong genetics research at Lund University, he has explored the mechanisms whereby genetic variation influences mitochondrial function and circadian regulation in the events leading to Type 2 Diabetes. His group has established a platform for use of induced pluripotent stem cells from patients with Type 2 Diabetes. These cells will be differentiated into mature cells in which pathogenic mechanisms in type 2 diabetes can be examined.

Hindrik Mulder has received the Anna-Greta Crafoord award for best thesis at the Medical Faculty in Lund, Carl Tesdorpf’s award, and the DPLU/LUDC Nordic prize for an Outstanding Young Diabetes Investigator. Hindrik Mulder is currently Editor-in-Chief of Diabetologia.